Embodied Conversational Agents for CervicalCancer Screening Abnormalities

ConditionCervical Cancer Screening

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age21-65

SponsorTufts Medical Center

About this trial

Many people who receive abnormal results from cervical cancer screening do not follow up with appointments that would allow treatment of precancer and would prevent cancer. In this project, we will develop an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age 21-65

has an abnormal cervical cancer screening test result

able to read in English or Spanish

Disqualifiers

planning to move out of the study area during the follow up period

pregnant

incarcerated

dose not have adequate vision or hearing to use the app

Trial design

Design model

Parallel

Treatments tested in this trial

embodied conversational agents for cervical cancer prevention
Behavioral
People receiving the intervention will receive an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.

Treatment groups

750 Participants

are divided into 3 treatment groups

Group A: ControlNo intervention 0 interventions

Group B: Conversational agent onlyExperimental treatment 1 intervention

Group C: conversational agent and advocacyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

The proportion of participants who receive recommended follow-up testing and treatment.

Time frame

18 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tufts Medical Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: